Literature DB >> 26437242

Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling.

Louis-Marie Charbonnier1, Sen Wang1, Peter Georgiev1, Esen Sefik2, Talal A Chatila1.   

Abstract

Receptors of the Notch family direct the differentiation of helper T cell subsets, but their influence on regulatory T cell (T(reg) cell) responses is obscure. We found here that lineage-specific deletion of components of the Notch pathway enhanced T(reg) cell-mediated suppression of type 1 helper T cell (T(H)1 cell) responses and protected against their T(H)1 skewing and apoptosis. In contrast, expression in T(reg) cells of a gain-of-function transgene encoding the Notch1 intracellular domain resulted in lymphoproliferation, exacerbated T(H)1 responses and autoimmunity. Cell-intrinsic canonical Notch signaling impaired T(reg) cell fitness and promoted the acquisition by T(reg) cells of a T(H)1 cell-like phenotype, whereas non-canonical Notch signaling dependent on the adaptor Rictor activated the kinase AKT-transcription factor Foxo1 axis and impaired the epigenetic stability of Foxp3. Our findings establish a critical role for Notch signaling in controlling peripheral T(reg) cell function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26437242      PMCID: PMC4618075          DOI: 10.1038/ni.3288

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


Notch signaling serves pleiotropic roles in the immune system by influencing multiple lineage decisions of developing lymphoid and myeloid cells [1, 2]. In mammals, the Notch family is composed by 4 Notch receptors (Notch1–4) and 5 ligands (Delta-like1, 3, and 4 and Jagged1 and 2). After ligand-receptor interaction, the intracellular domain of the Notch receptor is cleaved, traffics to the nucleus and forms complexes with the DNA binding factor RBPJ and the transcriptional co-activators MAML1-3, promoting expression of target genes. In addition to this canonical pathway, cleaved intracellular domains of Notch receptors engage non-canonical signaling components, including the metabolic checkpoint kinase complex mTORC2 and its associated adaptor Rictor [3, 4]. Notch intracellular domain also interacts with components of the NF-κB, TGF-β and the hypoxia response pathways [5, 6, 7]. Notch signaling is activated at various stages of commitment and development of T cell lineages, such as commitment to the T cell versus the B cell lineage, αβ versus γδ T cell differentiation and CD4 T versus CD8 single-positive T cell differentiation [1, 2], and during T cell-mediated immune responses, such as peripheral cytotoxic and helper T (TH) cell differentiation and function [8]. Pathogen-associated molecular patterns are known to promote expression of Notch ligand at the surface of antigen presenting cells. Activation of naive CD8+ T cells requires binding of Delta-like1 on antigen presenting cells by Notch1 or Notch2 leading to expression of Eomes, Gzmb, Ifng and Pfr1 [9, 10]. In naïve CD4+ T cells, Delta-like1 and 4 activate Notch signaling and Tbx21 transcription, encoding the TH1 transcriptional regulator T-bet [11, 12]. During TH2 differentiation, activation of Notch1 and 2 by Jagged1 and Jagged2 favor the expression of Gata3 and Il4 [13, 14, 15, 16]. Notch1 signaling has been described to be important in the differentiation of TH17 and TH9 subsets of helper T cells by promoting Rorc and Il9 expression, respectively [5, 17, 18]. The role of Notch signaling in the regulatory T (Treg) cell compartment remain controversial. In vitro, Jagged ligands and Notch 1 and Notch3 signaling seem to promote Treg cell differentiation and survival [3, 19, 20, 21]. In contrast, several in vivo studies have demonstrated that blockade of the Notch pathway, in particular Notch1 and Notch2, promotes tolerance in murine models of graft versus host disease, in association with the expansion of Treg cells [22, 23]. Studies have shown tolerogenic functions for antibodies to Notch1 in a humanized mouse model of vasculitis and in a murine model of aplastic anemia [24, 25]. In this study, we have employed Treg cell lineage-specific genetic and functional approaches to identify a key role for the Notch pathway in destabilizing Treg cells, promoting their apoptosis and inhibiting their function in the context of inflammation.

Results

Notch negatively regulates Treg cell functions and homeostasis

To elucidate the role of the Notch pathway in peripheral tolerance, we examined the functional consequences of interrupting Notch receptor signaling in a Treg cell-specific manner. To this end, we derived mice with a bacterial artificial chromosome (BAC) expressing an enhanced green fluorescent protein fused with the Cre recombinase under the control of Foxp3 promoter together with loxP-flanked Pofut1, encoding the enzyme protein O-fucosyltransferase 1 (called Foxp3EGFPCrΔ/Δ here; Supplementary Fig. 1a, b) [26]. The latter mediates fucosylation of Notch receptors, which is essential for receptor ligand interaction; its deficiency abrogates Notch signaling [26]. Treg cell-specific Pofut1 deficiency resulted in a decrease in peripheral CD3+ T cells and CD4+ T cell numbers by about 25% compared to Foxp3EGFPCr mice (Fig. 1a). It also resulted in a reciprocal increase in Treg cell frequency, with decreased CD4+CD62LloCD44hi T effector memory and a relative increase in CD62LhiCD44lo naïve T cells as compared to Foxp3EGFPCr mice (Fig. 1b–e). Expression of IFN-γ in splenic CD4+ T cells was markedly decreased in Foxp3EGFPCrePofut1Δ/Δ as compared to Foxp3EGFPCre mice, whereas expression of IL-17 was unaffected (Fig. 1f, g). Similar results were obtained for the IFN-γ production by CD8+ T cells (Fig. 1h, i). Expression of several Treg cell markers, including Foxp3, CD25, CTLA-4, Helios and neuropilin 1 (Nrp1) was increased in Pofut1-deficient compared to Foxp3EGFPCr Treg cells (Fig. 1j). We examined the role of the canonical Notch signaling in Treg cells by lineage-specific deletion of loxP-flanked Rbpj (Foxp3EGFPCreRbpjΔ/Δ; Supplementary Fig. 1a, b) [27]. The key phenotypes of Foxp3EGFPCrePofut1Δ/Δ mice were recapitulated in Foxp3EGFPCreRbpjΔ/Δ mice (Fig. 1a–j), indicating that the canonical pathway is the primary mediator of Notch signaling in Treg cells. Of the four Notch receptors, Notch1 was the most highly expressed in Treg cells, followed by Notch 2, whereas Notch3 and Notch4 expression was negligible (Supplementary Fig. 1c, d). The phenotype of mice with Notch1- deficient Treg cells, achieved by lineage-specific deletion of loxP-flanked Notch1 (Foxp3EGFPCreNotch1Δ/Δ; Supplementary Fig. 1a, b), approximated those of mice with Pofut- or RBPJ-deficient Treg cells, indicating that Notch1 was the main receptor through which Notch signaling was triggered in Treg cells (Fig. 1a–j) [28].
Fig. 1

Interruption of Notch signaling in Treg cells results in a super-regulatory phenotype

(a) Frequencies and numbers of CD3 and CD4 T cells from the spleen of 8 weeks old Foxp3EGFPCre, Foxp3EGFPCrePofutΔ/Δ, Foxp3EGFPCreRbpjΔ/Δ and Foxp3EGFPCreNotch1Δ/Δ mice. (b) Flow cytometric analyses of CD4 and Foxp3 markers on CD3+ T cells are shown. (c) Frequencies and numbers of Treg cells for each group of panel (a). (d) Flow cytometric analysis of CD62L and CD44 markers on CD4+ T cells are shown. (e) Frequencies and numbers of memory CD4+ T cells for each group. (f) Flow cytometric analyses of IFN-γ and IL-17 on CD4+ T cells are shown. (g) Frequencies and numbers of IFN-γ producing CD4+ T cells for each group. (h) Flow cytometric analyses of IFN-γ and IL-17 expression in CD8+ T cells. (i) Frequencies and numbers of IFN-γ producing CD8+ T cells shown in panel (H). (j) Expression of Foxp3, CD25, CTLA4, Helios and Nrp1 markers were evaluated of splenic Treg cells and expressed as mean fluorescence intensity (MFI). Results are representative of at least 3 experiments per panel. * p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001 by one way ANOVA with post test analysis.

We also assessed the effect of loss of function mutations in genes encoding members of the Notch pathway on the generation of thymus-derived Treg cells. We observed similar frequencies and numbers of Foxp3+ Treg cells among the mature CD4 single positive (CD4SP) thymocyte compartment in Foxp3EGFPCre, Foxp3EGFPCrePofut1Δ/Δ Foxp3EGFPCreRbpjΔ/Δ and Foxp3EGFPCreNotch1Δ/Δ mice (Supplementary Fig. 2a, b) we employed Foxp3YFPCre mice, which express a fusion of yellow fluorescent protein (YFP) and Cre recombinase in Treg cells under control of the endogenous Foxp3 locus [29]. We found that the in vitro differentiation of naive CD4+ T cells from Foxp3YFPCreRbpjΔ/Δ or Foxp3EGFPCreNotch1Δ/Δ into induced Treg (iTreg) cells was similar to that of Foxp3YFPCre control cells (Supplementary Fig. 2c, d). These results indicate normal thymic development and peripheral differentiation of Treg cell populations. To further elucidate the cell-intrinsic impact of loss of function Notch mutations on Treg cells, we took advantage of random X chromosome inactivation in females to analyze both central thymic and peripheral splenic Treg cells in heterozygous Foxp3YFPCre/+RbpjΔ/Δ female mice. Compared to heterozygote Foxp3YFPcre/+ littermate control female mice, in which approximately 50% of Treg cells within the thymus and spleen are YFP+, a higher proportion of YFP+ Treg cells was observed in the periphery of Foxp3YFPCre/+RbpjΔ/Δ females (Supplementary Fig. 2e, f). YFP+ Treg cells had higher expression of several Treg cell markers, including CD25, Helios and Nrp1 compared to YFP− Treg cells (Supplementary Fig. 2g, h). Overall, loss of function Notch signaling mutations exerted a positive, cell intrinsic effect on Treg cell fitness and function both at steady state and in the context of inflammation.

Treg cell-specific loss of Notch function protects mice from GVHD

We examined the suppressive capacities of Notch signaling-deficient Treg cells in the context of a strong inflammatory response, using the model of major histocompatibility complex (MHC) class I&II disparate graft versus host disease (GVHD). Adoptive transfer of T cell-depleted bone marrow from Foxp3EGFPCre, Foxp3EGFPCreRbpjΔ/Δ or Foxp3EGFPCreNotch1Δ/Δ C57Bl/6 mice into BALB/c mice lead to recovery from the lethal irradiation (Fig. 2a). Co-transfer of total spleen cells from Foxp3EGFPCre mice induced lethal GVHD, associated with expansion of donor-derived (H-2Kb+) IFN-γ-producing CD4+ and CD8+ T cells (Fig. 2a–f), while co-transfer of Foxp3EGFPCreRbpjΔ/Δ or Foxp3EGFPCreNotch1Δ/Δ total spleen cells resulted in protection from lethal GVHD in recipient mice, with attenuated GVHD severity scores and decreased IFN-γ production by donor T cells (Fig. 2a–f). Moreover, transfer of total spleen cells from Foxp3EGFPCreRBPJΔ/Δ or Foxp3EGFPCreNotch1Δ/Δ mice lead to increased frequency and number of donor Treg cells, associated with decreased apoptosis, as assessed by Annexin V (AnnV) staining, and decreased IFN-γ production (Fig. 2c–d, g–j). In the context of exaggerated inflammation induced by GVHD, donor Foxp3EGFPCre Treg cells exhibited higher expression of the cleaved intracellular domain of Notch1 (N1c), as compared to their CD4+Foxp3− Tconv cell counterparts (Fig. 2h–i) Together, these results reveal a direct role for cell-intrinsic Notch signaling in destabilizing Treg cells in the context of inflammation by promoting their apoptosis and IFN-γ production.
Fig. 2

Treg cell-specific loss of function Notch signaling mutations protect mice from lethal graft versus host disease

(a) Survival and (b) severity score of lethally irradiated (8.5/9Gy) BALB/c mice infused with C57Bl/6 Foxp3EGFPCre, Foxp3EGFPCreRbpjΔ/Δ or Foxp3EGFPCreNotch1Δ/Δ T cell-depleted bone marrow, either alone (BM only) or together with spleen cells of the respective genotypes. For T cell subpopulation analyses were carried out on spleen cells at day 5 post adoptive transfer. The BM only groups were not included in panel b. (c) Flow cytometric analyses of IFN-γ and Foxp3 markers on CD4+ T cells are shown. (d) Frequencies of IFN-γ producing CD4+ Tconv (Foxp3−) and Treg (Foxp3+) cells for each group. (e) Flow cytometric analyses of IFN-γ and IL-2 markers on CD8+ T cells. (f) Frequencies and numbers of IFN-γ producing CD8+ T cells for each group. (g) Flow cytometric analyses of Foxp3 marker on CD4+ T cells are shown. (h) Frequencies and numbers Treg cells for each group. (i) Viability dye and Annexin V (AnnV) staining of Treg cells are shown (j) Frequencies of apoptotic (AnnV+) Tconv and Treg cells for each group. (k) Overlay of representative N1c expression on Tconv and Treg cells are shown. (l) MFI of N1c expression in Tconv and Treg cells for each group. Results are representative of at least 2 experiments per panel. * p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001 by log-rank test, one way ANOVA and two way ANOVA with post test analysis.

Treg cell-specific gain of Notch function disrupts peripheral tolerance

To investigate the role of Notch1 signaling in Treg cells, we generated Foxp3EGFPCreRosa26N1/N1c mice, which constitutively express N1c in their Treg cells (Supplementary Fig. 1e) [30]. We found increased expression of N1c in Foxp3EGFPCreRosa26N1/N1c Treg cells, associated with heightened expression of several Notch signaling target genes, including Hes1, Hey1, Heyl and Dtx1 (Supplementary Fig. 1f, g). In contrast to the mutations that resulted in loss of Notch function, constitutive expression of N1c in Treg cells resulted in an autoimmune lymphoproliferative disease, whose manifestations included large vessel vasculitis and lymphocytic end organ infiltration in the Foxp3EGFPCreRosa26N1/N1c mice (Fig. 3a, b). The CD4+CD62LloCD44hi T effector memory cell pool was expanded and the numbers of CD4+ and CD8+ T cells expressing IFN-γ were increased by 50%, while the frequency of Treg cells was decreased by 45% (Fig. 3c, d). There was also dysregulation of the B cell compartment with significant increase of several circulating autoantibodies (to 18 out of 98 screened endogenous antigens) in Foxp3EGFPCreRosa26N1/N1c mice as compared to Foxp3EGFPCre mice (Fig. 3e). Overexpression of N1c in Treg cells dramatically worsened the incidence and severity of type I diabetes in the genetically susceptible NOD mice, particularly in normally resistant NOD males (Fig. 3f–h). Whereas N1c expression in T cell precursors precipitates the occurrence of T cell acute lymphocytic leukemia, no evidence of leukemia was found in Foxp3EGFPCreRosa26N1c/N1c mice up to 6 months of age (data not shown) [4].
Fig. 3

Exacerbated Notch signaling in Treg cells results in immune dysregulation and autoimmunity

(a) A representative picture of spleens and peripheral lymph nodes from 6 months old Foxp3EGFPCre and Foxp3EGFPCreRosa26N1c/N1c mice. (b) Representative pictures of H&E staining of lung, spinal vessels, spinal cord and pancreas from 6 month old Foxp3EGFPCreRosa26N1c/N1c mice. Frequencies (c) and numbers (d) of CD3, CD4, CD8 T cells, Treg cells, IFN-γ producing CD4 and CD8 T cells and memory CD62LloCD44hi CD4 T cells from the spleen of 8 weeks old Foxp3EGFPCre (white circles) and Foxp3EGFPCreRosa26N1c/N1c (black circles) mice. (e) Heatmap summarizing the expression of circulating autoantibodies significantly increased in 8 weeks old Foxp3EGFPCreRosa26N1c/N1c compared to Foxp3EGFPCre mice (serum from Foxp3K276X was used as a positive control). (f) Diabetes incidence of littermate control and Foxp3EGFPCreRosa26N1c/N1c female (n=18 and n=13 respectively) and male (n=16 and n=8 respectively) mice on NOD background. (g, h) Representative pictures of H&E staining of pancreas and histological score of 15 weeks old control females (white circles) or males (white squares) and Foxp3EGFPCreRosa26N1c/N1c females (Black circles) or males (black squares) on NOD background. * p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001 by unpaired two-tailed Student’s t-test and log-rank test.

Analysis of Foxp3EGFPCreRosa26N1c/N1c mice revealed an age-dependent increase in the frequency of Treg cells that do not express the Foxp3 BAC-driven EGFP-Cre transgene (data not shown). Accumulation of EGFP− Treg cells was observed during thymic development and reached up to 30% of the peripheral Treg cell pool at 2 month of age (Supplementary Fig. 3a, b). EGFP− Treg cells were observed at very low frequencies in Foxp3EGFPCre, Pofut1, RBPJ or Notch1 mice (data not shown). Whereas the GFP+ Foxp3EGFPCreRosa26N1c/N1c Treg cells expressed high amounts of N1c, consistent with the expression of the transgene from the Rosa26 locus, N1c expression in GFP− Foxp3 Treg cells was similar to that of control Foxp3EGFPcre Treg cells (Supplementary Fig. 3c), suggesting that the GFP− Treg cells never expressed the Foxp3EGFPcre BAC gene and that transgenic expression of N1c induced a profound competitive disadvantage in Treg cells. To overcome this 'escape' phenotype, we used Foxp3YFPCre mice that expressed a YFP-Cre fusion protein under control of the endogenous Foxp3 locus [29]. Unlike Foxp3EGFPCreRosa26N1c/N1c mice, 95% of Foxp3YFPCreRosa26N1c/N1c Treg cells expressed the Foxp3-driven Cre recombinase (Supplementary Fig. 3d, e). Analysis of heterozygous Foxp3YFPCre/WTRosa26N1c/N1c females revealed marked skewing of X-chromosome utilization by Treg cells in the periphery in favor of expressing the Foxp3WT allele (Supplementary Fig. 3f, g). YFP+ Foxp3YFPCre/WTRosa26N1c/N1c Treg cells expressed significantly lower amounts of Foxp3 compared to their YFP− Treg cell counterparts (Supplementary Fig. 3h, i). Double mutant Foxp3YFPCreRosa26N1c/N1c male mice developed a more aggressive and accelerated autoimmune lymphoproliferative disease than Foxp3EGFPCreRosa26N1c/N1c males, as revealed by tissue histology and immunological analyses (Supplementary Fig. 4). Altogether, these data indicate a profoundly deleterious impact of N1c expression on Treg cell fitness. Flow cytometric analysis of peripheral Treg cells in the Foxp3EGFPCreRosa26N1c/N1c and Foxp3YFPCreRosa26N1c/N1c mice revealed decreased expression of Treg cell markers, including Foxp3, CD25, CTLA-4, OX40, Helios, Nrp1 and Eos (Fig. 4a and Supplementary Fig. 5a, b). Foxp3EGFPCreRosa26N1c/N1c Treg cells exhibited increased Ki67 expression, consistent with heightened cellular proliferation, and increased apoptosis, as detected by AnnV staining, as compared to Foxp3EGFPCre and Foxp3EGFPCreRbpjΔ/Δ Treg cells (Fig. 4b, c). In vitro, the suppressive capacity of Foxp3EGFPCreRosa26N1c/N1c Treg cells was decreased, whereas that of Foxp3EGFPCreRbpjΔ/Δ Treg cells was enhanced compared to Foxp3EGFPCre Treg cells (Fig. 4d). The generation of thymic Treg cells in Foxp3EGFPCreRosa26N1c/N1c mice proceeded unaffected as similar frequencies and numbers of Foxp3+ cells among CD4 single positive thymocytes were found in Foxp3EGFPCre and Foxp3EGFPCreRosa26N1c/N1c mice (Supplementary Fig. 5c–d). In addition, the demethylation status of the conserved non-coding sequence 2 (CNS2) CpG elements in the Foxp3 promoter was similar in thymic Treg cells of Foxp3EGFPCre and Foxp3EGFPCreRosa26N1c/N1c mice. (Supplementary Fig. 5e–f). In vitro, the differentiation of naive CD4+ Foxp3YFPCreRosa26N1c/N1c T cells into induced Treg (iTreg) cells following stimulation with anti-CD3+CD28 mAb and TGF-β was decreased compared to those of Foxp3YFPCre mice (Supplementary Fig. 5g, h), suggesting an inhibitory function of N1c in both thymus and periphery-derived Treg cells. Next, we investigated the effect of N1c on the ability of adoptively transferred Treg cells to suppress colitis in Rag1-deficient mice. Naive CD45RbhiCD4+ Tconv cells were isolated from CD45.1+ Foxp3EGFPCre donor mice and transferred alone or in combination with Treg cells from CD45.2+ Foxp3EGFPcre or CD45.2+ Foxp3EGFPcreRosa26N1c/N1c mice into T cell–deficient Rag1−/− host mice. We found that such co-transfer of Treg cells from CD45.2+ Foxp3EGFPcreRosa26N1c/N1c mice failed to suppress the colitis induced by the transfer of naive CD45.1+ CD45RbhiCD4+ Tconv cells: the recipient Rag1−/− mice exhibited substantial weight loss and tissue inflammation, as well as shorter colons and excess generation of IFN-γ+ and IL-17+ CD45.1+ effector T cells (Fig. 4e–i). Analysis of the CD45.2 cell compartment in recipient mice at d35 showed increased EGFP loss in Foxp3EGFPCreRosa26N1c/N1c (60%) as compared to control Foxp3EGFPCre cells (45%) (Fig. 4j), indicative of the heightened instability of N1c-expressing Treg cells.
Fig. 4

Notch signaling compromises Treg cell phenotype and suppressive functions

(a) Expression of Foxp3, CD25, CTLA4, OX40, Helios, Nrp1 and Eos markers were evaluated in splenic Treg cells of Foxp3EGFPCre (Dashes lines and white circles) and Foxp3EGFPCreRosa26N1c/N1c (Solid lines and black circles) mice. Gray plains represent expression of those markers in Tconv of Foxp3EGFPCre mice. Cell turn-over was assessed in Treg cells of Foxp3EGFPCre (Dashes lines and white circles), Foxp3EGFPCreRosa26N1c/N1c (Solid black lines and black circles) and Foxp3EGFPCreRbpjΔ/Δ (Solid gray lines and Gray triangles) by Ki67 staining (b) for active cell cycle phases and by AnnV staining (c) for apoptosis. (d) In vitro suppression of responder CD4+ T cell proliferation (TEff) was assessed by evaluation of proliferation dye dilution upon anti- CD3/C28 stimulation in the presence of various number of Treg cells from each genotype. In vivo suppressive capacity of Treg cells from Foxp3EGFPCre (white circles), Foxp3EGFPCreRosa26N1c/N1c (black circles) was assessed in the CD4 T cell transfer-induced colitis model. (e) Changes in body weight over time are shown (n=4–7). One representative experiment of 3 is shown. (f–h) Disease severity was evaluated by H&E staining of colon sections and end point colon length. (i) Absolute number of total, IFN-γ and IL-17-producing CD45.1+CD4+ T cells from the naïve T cell input was quantified within the entire colon. (j) Stability of Treg cell lineage was shown by percent of EGFP expression of the CD45.2 T cell compartment. * p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001 by unpaired two-tailed Student’s t-test, One way ANOVA with post test analysis and two way ANOVA.

To delineate the intrinsic impact of N1c on the functional phenotype of Treg cells, as opposed to a cell-extrinsic effect mediated by systemic inflammation, we analyzed heterozygous Foxp3YFPCre/WTRosa26N1c/N1c female mice for lymphoproliferation, immune cell activation and Treg cell phenotype. In contrast to homozygous Foxp3YFPCre/YFPCreRosa26N1c/N1c females, Foxp3YFPCre/WTRosa26N1c/N1c females exhibited no signs of lymphoproliferation or TH1 skewing of CD4+ Tconv cells at steady state (Supplementary Fig. 6a–d). However, YFP+ Treg cells from Foxp3YFPCre/WTRosa26N1c/N1c females showed decreased expression of Treg cell markers such as Foxp3, CD25, CTLA4, OX40, Helios and Nrp1, as compared to YFP− Treg cells from the same mice (Supplementary Fig. 6e, f). These results indicate that N1c overexpression destabilizes the phenotype and impairs the function of Treg cells by a cell-intrinsic mechanism, leading to immune cell activation, lymphoproliferation and autoimmunity.

The canonical Notch pathway mediates Treg cell destabilization

To determine the overall contribution of the canonical Notch pathway to the inflammation and autoimmunity observed in Foxp3EGFPCreRosa26N1c/N1c mice, we concurrently deleted Rbpj in the Treg cells of these mice. Most major phenotypes of Foxp3EGFPCreRosa26N1c/N1c mice, including lymphoproliferation, T cell activation, TH1 and TC1 skewing, autoantibody production and alterations in Treg cell markers and suppressor function were reversed in Foxp3EGFPCreRosa26Nc1/N1cRbpjΔ/Δ mice (Fig. 5a–i). Thus, activation of canonical Notch signaling has a predominant role in the immune dysregulation observed in the Foxp3EGFPCreRosa26N1c/N1c mice.
Fig. 5

Treg cell failure and disease manifestations in Foxp3EGFPCreRosa26N1c/N1c mice proceed by a canonical pathway dependent mechanism

(a) Frequencies and numbers of CD3, CD4 and Treg cells from the spleen of 8 weeks old Foxp3EGFPcre, Foxp3EGFPCreRosa26N1c/N1c, Foxp3EGFPCreRbpjΔ/Δ and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice. (b) Flow cytometric analysis of CD62L and CD44 markers on CD4+ T cells. (c) Scatter plots represent frequencies and numbers of memory CD4+ T cells for each group. (d) Flow cytometric analysis of IFN-γ and IL-17 secretion by CD4+ T cells are shown. (e) Scatter plots represent frequencies and numbers of IFN-γ producing CD4+ T cells for each group. (f, g) Expression of Foxp3, CD25, Helios, Nrp1 markers were evaluated in splenic Treg cells of each group. n=4–5 per group. (h) In vitro suppression of responder CD4+ T cell proliferation (TEff) was assessed by evaluation of proliferation dye dilution upon anti-CD3/C28 stimulation in the presence of various number of Treg cells from each genotype. (I) Heatmap summarizing the expression of significantly modulated circulating autoantibodies in 8 weeks old Foxp3EGFPCre, Foxp3EGFPcreRosa26N1c/N1c and Foxp3EGFPcreRBPJΔ/Δ and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice (serum from Foxp3K276X was used as positive control). One representative experiment of 2 or 3 is shown for panels (a-h). * p<0.05 and ** p<0.01 by One way ANOVA with post test analysis and two way ANOVA.

Notch activates RBPJ-dependent and independent transcription in Treg cells

Treg cells have a transcriptional signature reflective of their regulatory function [31, 32, 33]. We compared the transcriptional profiles of splenic Treg cells isolated from Foxp3EGFPCre, Foxp3EGFPCreRosa26N1c/N1c, Foxp3EGFPCreRbpjΔ/Δ and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice. We compared the transcriptional profiles of splenic Treg cells isolated from Foxp3EGFPCre, Foxp3EGFPCreRosa26N1c/N1c, Foxp3EGFPCreRbpjΔ/Δ and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice. Comparison of the transcriptional profiles of Foxp3EGFPCreRosa26N1c/N1c Treg cells and Foxp3EGFPCre Treg cells revealed a limited set of genes whose transcription was affected by N1c expression (mean expression value, >120; false-discovery rate, <0.1; coefficient variation, <0.5; Fig. 6a). Plotting of the transcriptional profiles as the difference in expression in Foxp3EGFPCreRosa26N1c/N1c Treg cells versus Foxp3EGFPCre Treg cells against the difference in expression Foxp3EGFPCreRosa26N1c/N1c RbpjΔ/Δ Treg cells versus Foxp3EGFPCre Treg cells revealed both RBPJ-dependent alterations in gene expression and RBPJ-independent alterations in gene expression (Fig. 6b). Hierarchal clustering analysis of genes whose expression was significantly altered by N1c expression revealed a subgroup of genes that were either upregulated (Dtx1, Ifng, Gzmb, Pde3b) or down-regulated (Nrp1, Socs2, Il1rl1, Ikzf2, Ikzf4) in an RBPJ-dependent manner (Fig. 6c). A second subgroup included genes that were modulated by N1c in an RBPJ-independent manner, consistent with their regulation by non-canonical pathway(s) (Fig. 6d). This subgroup included genes downstream of Foxo1 signaling, such as Bmp7, Gzma, Cd55 and others [34, 35, 36]. These results indicated a profound impact of Notch signaling on the Treg cell transcriptome by both canonical and non-canonical pathways.
Fig. 6

Impact of Notch signaling on the Treg cell transcriptome

(a) Microarray analysis of gene expression (mean) of Foxp3EGFPCreRosa26N1c/N1c (n = 4) (X axis) versus Foxp3EGFPCre Treg cells (n=4). Numbers in plots indicate total genes downregulated (red) or upregulated (blue) in N1c overexpressing Treg cells relative to their expression in Foxp3EGFPCr Treg cells (cutoff of a two fold change). (b) Comparison of changes in gene expression induced by Notch1 signaling (Foxp3EGFPCreRosa26N1c/N1c vs Foxp3EGFPCre; horizontal axis) and those induced by Notch gain of function in absence of canonical pathway (Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ vs Foxp3EGFPCre; vertical axis) within Treg cells. Blue lines mark a fold change of 2. (c, d) Genes whose expressions are significantly modulated (p<0.05 by one way ANOVA) were segregated in 2 clusters based on the pattern of modulation (canonical and non-canonical) and representative heat maps for each cluster are shown.

We further analyzed the binding of RBPJ at two Foxp3-regulated genes that were affected by N1c expression. These included Pde3b, whose expression is normally suppressed by Foxp3, but was upregulated by N1c expression in Treg cells, and Ikzf2, whose expression is normally upregulated by Foxp3, but was decreased by N1c. Chromatin-immunoprecipitation analysis indicated that Foxp3 binding to the Pde3b and Ikzf2 promoters was decreased, and that of RBPJ was increased, in Foxp3EGFPCreRosa26N1c/N1c as compared to Foxp3EGFPCre Treg cells (Supplementary Fig. 7a, b). Analysis of epigenetic histone-methylation markings at the Pde3b promoter revealed more H3K4me3 and less H3K27me2 in Foxp3EGFPCreRosa26N1c/N1c Treg cells than in Foxp3EGFPCre Treg cells (Supplementary Fig. 7a), a pattern associated with decreased Foxp3-dependent suppression of gene expression[37]. Reciprocally, H3K27me2 was increased at the Ikzf2 promoter (Supplementary Fig. 7b). These results indicate that canonical Notch signaling directly targeted a subset of Foxp3-regulated genes, antagonized Foxp3 binding and altered Foxp3-induced epigenetic markings at those loci.

The Notch canonical pathway mediates TH1 reprograming of Treg cells

Aborted TH1 programming provides a mechanism by which Treg cells restrain TH1 responses [38]. Treg cells respond to IFN-γ treatment by upregulating Tbx21 expression in a STAT1-dependent manner [38]. T-bet expression in Treg cells induces a partial Th1 program, including expression of CXCR3, but fails to upregulate expression of IL-12Rβ2, necessary to complete STAT4-dependent TH1 differentiation [39]. N1c over-expression in Foxp3EGFPCreRosa26N1c/N1c Treg cells upregulated the transcription of several genes associated with TH1 cells, including Il12rb2 and Ifng as well as a number of genes downstream of IL-12-STAT4 signaling, including Ffar1, Id2 and Nkg7 (Fig. 7a and Supplementary Table 1). Treatment of Foxp3EGFPCreRosa26N1c/N1c Treg cells with IL-12 lead to expression of IFN-γ, which was lost in Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ Treg cells (Fig. 7b, c). Treatment with IL-12 resulted in the phosphorylation of STAT4 in a subset of N1c-expressing Treg cells in an RBPJ-dependent manner (Fig. 7d, e). Foxp3EGFPCreRosa26N1c/N1c Treg cells exhibited increased RBPJ and N1c binding to the Ifng CNS22 element, which mediates transcriptional activation of Ifng by Notch signaling in cooperation with T-bet (Fig. 7f, g) [40]. IL-12-induced STAT4 phosphorylation was only observed in YFP+, but not YFP− Treg cells from heterozygous Foxp3YFPcre/+Rosa26N1c/N1c females (Supplementary Fig. 6g, h), indicating that expression of Il12rb2 in Foxp3YFPcre/WTRosa26N1c/N1c Treg cells was due to intrinsic N1c-overexpressing and not to systemic inflammation. These results indicated that N1c promoted TH1 programming of Treg cells in a cell-intrinsic and canonical pathway-dependent manner.
Fig. 7

N1c mediates TH1 reprogramming of Treg cells

(a) qPCR analysis of Il12rb2 and Ifng transcripts in Treg cells isolated from Foxp3EGFPCre, Foxp3EGFPCreRosa26N1c/N1c and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice (n=4–6 per group). Results represent mean fold change + S.E.M. compared to mean of Foxp3EGFPCre Treg cells. Representative flow cytometry dot plots (b) and histograms (c) of IFN-γ production by sorted Treg cells after ex-vivo IL-12 stimulation (n=3 per group). Representative histograms (d) and dot plots (e) of P-STAT4 on gated Foxp3−CXCR3+ and CD4+Foxp3+CXCR3+ cells after CD4 enrichment and IL-12 stimulation (n=3–8 per group). ChIP graphs represent quantitative PCR analysis of the ratio of enriched Ifng CNS22 binding site immuneprecipitated with anti-RBPJ (f) and anti-N1c (g) to the input DNA on Treg cells isolated from Foxp3EGFPCre, Foxp3EGFPCreRosa26N1c/N1c and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice (n=3 per group). * p<0.05, ** p<0.01 and *** p<0.001 by unpaired two-tailed Student’s t-test and One Way ANOVA with post test analysis.

Notch regulates Foxp3 epigenetic stability via Rictor

Notch signaling activates the mammalian target of Rapamycin (mTOR) kinase complex 2 (mTORC2) and its downstream kinase AKT independent of RBPJ[3, 4, 41]. AKT phosphorylates the transcription factor Foxo1, resulting in its retention in the cytosol and its ubiquitinaiton and degradation[42, 43]. In turn, Foxo1 negatively regulates Th1 differentiation of Treg cells by suppressing Ifng transcription, as well as other type 1 genes [35, 44]. Because N1c overexpression increased the transcription of Foxo1- suppressed genes in Foxp3EGFPCreRosa26N1c/N1c Treg cells, we examined mTORC2-Akt activation in these cells. Anti-CD3+CD28 mAb treatment resulted in increased phosphorylation of S473 in AKT, which is a target of mTORC2, in Foxp3EGFPCreRosa26N1c/N1c Treg cells, but not in control Foxp3EGFPCre Treg cells. Anti-CD3 mAb treatment did not induce the phosphorylation of T308 in AKT, which is a target of phospho-inositide 3-kinase (PI3K) (Fig. 8a, b and data not shown). AKT S473 phosphorylation was detected in Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ Treg cells as well, suggesting it was independent of RPBJ (Fig. 8a, b). AKT S473 phosphorylation was not observed in Foxp3EGFPCreRosa26N1c/N1cRictorΔ/Δ Treg cells, bearing a Foxp3-driven deletion of Rictor, an essential component of the mTORC2 complex following anti- CD3+CD28 mAb stimulation (Supplementary Fig. 1a, b). In contrast, AKT S473 phosphorylation proceeded unaffected in stimulated CD4+ Tconv cells of all genotypes (Fig. 8a, b). There was increased Foxo1 translocation to the cytosol upon CD3 activation in Foxp3EGFPCreRosa26N1c/N1c Treg cells, which was partially reversed by Rictor but not by RBPJ deficiency in these cells (Fig. 8c, d).
Fig. 8

Rictor-dependent non-canonical signaling dysregulates AKT-Foxo1 axis in Foxp3 Treg cells

(a) Flow cytometric analysis and (b) scatter plot analysis of MFI of unstimulated and anti-CD3/anti-CD28 stimulated Treg cells from Foxp3EGFPCre, Foxp3EGFPCreRosa26N1c/N1c, Foxp3EGFPCreRosa26N1c/N1cRictorΔ/Δ and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice. (c) N1c augments anti-CD3 mAb-induced translocation of nuclear Foxo1 to the cytosol in a Rictor dependent manner. Unstimulated and anti-CD3 mAb stimulated Treg cells were stained for nuclear DNA (DAPI) and Foxo1 and examined by confocal microscopy for Foxo1 distribution in the nucleus vs. cytosol. (d) Quantitation of percent Foxo1 nuclear expression. Each point represents one cell. (e) Flow cytometric analyses of Foxp3 and EGFP expression in peripheral Treg cells from Foxp3EGFPCreRosa26N1c/N1c, Foxp3EGFPCreRosa26N1c/N1cRictorΔ/Δ and Foxp3EGFPCreRosa26N1c/N1cRbpjΔ/Δ mice. (f) Fractions of EGFP+ cells among Foxp3+ Treg cells from panel (e). (g) Methylation status of individual CpG motifs within the TSDR of CNS2 in Foxp3. Individual CpG motifs are numbered with reference to the transcription initiation site of Foxp3. (h) Global methylation status of the TSDR of CNS2 in Foxp3. * p<0.05, ** p<0.01 and *** p<0.001 by unpaired two-tailed Student’s t-test and One Way ANOVA with post test analysis.

Analysis of Foxp3EGFPCreRosa26N1c/N1cRictorΔ/Δ mice revealed that the frequencies and absolute numbers of splenic Treg and IFN-γ+CD4+ Tconv cells were decreased and the lymphoproliferative disease was reduced as compared to Foxp3EGFPCreRosa26N1c/N1c mice, (Supplementary Fig. 8a,b). However, in the absence of N1c overexpression, Rictor deficiency did not impact the frequencies or the total numbers of IFN-γ+ CD4+ T cells, memory CD4+ T cells or Treg cells in Foxp3 as compared to Foxp3 mice (Supplementary Fig. 8c, d). Importantly, the escape of Foxp3 Treg cells away from expressing the Foxp3 BAC transgene was ameliorated by concurrent RBPJ but not Rictor deficiency, indicative of the failure of Rictor deficiency to correct the impaired fitness of N1c–expressing Treg cells (Fig. 8e, f). However, expression of key Treg cell markers was improved in Foxp3EGFPCre Rosa26N1c/N1cRictorΔ/Δ as compared to Foxp3EGFPCreRosa26N1c/N1c Treg cells (Supplementary Fig. 8e, f). Epigenetic demethylation of the Foxp3 CNS2 region has been linked to sustained Foxp3 expression and overall Treg cell stability [45, 46]. The demethylation of the Foxp3 CNS2 region was decreased in Foxp3EGFPCrN1c/N1c as compared to Foxp3EGFPCre Treg cells, which was largely reversed by concurrent Rictor but not RBPJ deficiency (Fig. 8g, h). These findings indicated that N1c destabilized Treg cells in part by altering their Foxp3 CNS2 epigenetic demethylation signature in a Rictor-dependent manner.

Discussion

In this study, we provide evidence that cell-intrinsic Notch signaling regulates the Treg cell compartment in the periphery and controls Treg cell programming towards a TH1 phenotype, as well as TH1 cell responses. Blockade of different steps of the Notch signaling pathway in Treg cells, by means of lineage-specific targeted gene inactivation of Pofut1, Rbpj or Notch1, resulted in increased Treg cell frequency, decreased CD4+ T cell compartment size, and decreased IFN-γ production by CD4 and CD8 cells. Treg cell-specific deletion of Notch signaling components protected against full MHC-mismatched GVHD in association with decreased Treg cell apoptosis, Treg cell programing towards a TH1 phenotype and alloreactive TH1 and TC1 responses. Reciprocally, over-expression of N1c in Treg cells resulted in lymphoproliferation, increased Treg cell apoptosis, TH1 programing of Treg cells, dysregulated TH1 and TC1 responses and autoimmunity. N1c expression down-regulated the expression of several critical components of the Treg cell transcriptome and weakened the Treg cell epigenetic imprint. Thus, homeostatic Notch signaling in Treg cells defines the size and function of the Treg cell compartment and controls the magnitude of TH1 and TC1 cell responses in vivo. The effects of Notch signaling on Treg cells were predominantly exerted by the canonical pathway. Interruption of the canonical Notch pathway by means of Treg cell-specific Rbpj deletion rescued the key manifestations associated with enforced N1c expression in Treg cells, including lymphoproliferation and autoimmunity. Several Treg cell phenotypic, transcriptional and functional alterations induced by enforced N1c expression were reversed upon RBPJ deletion, indicating their dependence on canonical Notch signaling. RBPJ bound to a subset of Foxp3 target gene, such as Pde3b and Ikzf2, antagonized the binding of Foxp3 and reversed the Foxp3-associated histone methylation profile at those loci, indicative of a direct effect of the canonical pathway on at least a subset of Foxp3-regulated genes. Additional regulation may also be exerted by downstream gene targets of Notch signaling, such as Hes1 and Dtx1, which may engage in secondary transcriptional circuits that contribute to gene expression changes induced by Notch in Treg cells. In contrast to the above, a number of Treg cell transcripts appeared to respond to Notch signaling in a canonical pathway-independent manner. Several of these have been previously associated with Foxo1 dependent regulation, consistent with their induction by the mTOR-AKT-Foxo1 pathway. N1c-driven impairment of epigenetic demethylation of Foxp3 CNS2 was also independent of the canonical pathway, suggesting a putative role for non-canonical signaling in Notch-mediated Treg cell destabilization. This conclusion was reinforced by the demonstration that N1c-induced increase in CpG methylation of Foxp3 CNS2 was largely reversed in N1c overexpressing but Rictor deficient Treg cells These studies highlight the important role played by canonical Notch signaling in Treg cells in enabling TH1 and TC1 responses. In the course of controlling a TH1 response, Treg cells normally undergo an aborted program of TH1 differentiation that limits their capacity to express IL-12Rβ2 [38]. Activation of the canonical Notch signaling bypassed this blockade, leading to STAT4 activation and IFN-γ production in response to IL-12 in Treg cells. RBPJ and N1c associated with CNS22 in the Ifng locus in N1c-overexpressing Treg cells, consistent with previous data showing direct activation of Ifng expression by Notch signaling in synergy with T-bet [40]. N1c also enabled more effective activation of mTORC2-AKT by TCR engagement and Foxo1 cytosolic sequestration, a mechanism previously implicated (by means of CD4+ T cell- or Treg cell-specific Foxo1 deletion) in promoting TH1 differentiation of Treg cells [34, 35, 44]. The two mechanisms, canonical and non-canonical, may thus act cooperatively to induce TH1 skewing. Notch signaling in Treg cells played a particularly deleterious role in the context of severe inflammation in the full MHC-mismatched GVHD. Whereas control (Foxp3EGFPCre) Treg cells were susceptible to apoptosis and TH1 programming, Notch1 or RBPJ-deficient Treg cells were resistant to both processes, leading to the accumulation of Treg cells, decreased skewing towards the TH1 phenotype and increased survival. Notch1 inactivation in T cells protects against GVHD[22], and our studies indicated that Treg cells were the key cellular effectors of this effect. In the context of overwhelming TH1 immune responses, such as experimental T. gondii infection, Treg cells undergo TH1 programming and apoptosis, recapitulating the fate of Treg cells in GVHD [47]. The exaggerated TH1 response in T. gondii-infected mice was associated with decreased IL- 2 production, which contributed to Treg cell apoptosis. In addition, interference with Notch signaling in Treg cells attenuated the TH1 and TC1 response and increased IL-2 production, consistent with a role for IL-2 in enhanced survival of Notch-deficient Treg cells in GVHD. The inhibitory effects of Notch signaling on Treg cell function offer mechanistic insights into how blockade of Notch receptors may induce tolerance, as has been reported in some experimental mouse models of graft versus host disease. Intervention strategies targeting the Notch pathway may thus offer innovative therapeutic approaches in transplant and autoimmune diseases.

Online Methods

Mice

Foxp3EGFPCre, Foxp3YFPCre, Notch1fl/fl, Rosa26N1c/N1c, Rag1−/−, CD45.1, Foxp3EGFP and BALB/c mice were obtained from the Jackson Laboratory [28, 30, 48]. Rictorfl/fl mice were obtained from the Mutant Mouse Regional Resource Center. Pofut1fl/fl and Rbpjfl/fl were kind gifts of Pamela Stanley and Tasuku Honjo, respectively, and were generated as described [26, 27]. All Foxp3 mutant mouse strains and their respective crosses were backcrossed 8–10 generations on C57BL/6 or NOD background where specified. Excepted when it was specified, 8 weeks old mice were used in this study. The mice were housed under specific pathogen-free conditions and used according to the guidelines of the institutional Animal Research Committees at the Boston Children’s Hospital.

Real-time PCR

Total RNA was isolated from sorted cells with RNeasy kit (Qiagen). Reverse transcription was performed with the SuperScript III RT-PCR system (Invitrogen) and quantitative real-time reverse transcription (RT)-PCR with Taqman® Fast Universal PCR master mix, internal house keeping gene mouse (GAPD VIC-MGB dye) and specific target gene primers (FAM Dye) (Applied Biosystems) on Step-One- Plus machine. Relative expression was normalized to GAPD for Notch1-4 receptor and calculated as fold change compared to wild-type CD4+GFP− conventional T cells for Pofut1, Notch1, RBPJ and Rictor regarding the regulatory T cell-specific deficiency and fold change normalized to wild-type Treg cells for IFNg and IL12rb2.

Flow cytometry

Annexin V and antibodies against CD4, CD8, CD16/CD32, CD90.2, CTLA4, ICOS, H-2Kd (biolegend), CD3Σ, CD25, CD44, CD45.1, CD45.2, CD45Rb, CD62L, Eos, Foxp3, Helios, IFN-γ, IL-17A, IL-2, Ki67, OX40, CXCR3, H-2Kb (eBioscience), N1c, P-STAT4 (BD biosciences), P-AKT (S473) (Cell signaling) and Nrp1 (R&D system) were used. Cell suspensions were incubated for 10 min with CD16/CD32 then stained for surface markers for 20 min on PBS/1%FCS. Foxp3, Helios, Eos, CTLA4, Ki67 staining was performed by using eBioscience Fixation/Permeabilization kit. For cytokine detection, cell suspensions were pre-incubated with 50 ng/mL PMA, 500 ng/mL ionomycin and 10 μg/mL brefeldin A for 4h in complete medium before CD16/32 blocking followed by surface staining, permeabilization and intracellular Foxp3, IFN-γ, IL-2 and IL-17 staining. For phospho-AKT experiments, spleen cells were stimulated for 30 min with soluble anti-CD3 (1μg/mL) and anti-CD28 (5μg/mL). In some experiments, spleen cells were pre-treated with Rapamycin (250nM, Tocris) for 0, 1 or 24h. After stimulation, cells are fixed with PBS/2%PFA for 20min, permeabilized in 90% methanol for 30 min on ice and stained for CD4, Foxp3 and PS473-AKT. For phospho-STAT4 experiments, splenic CD4+ T cells were isolated and stimulated for 30min with 25ng/mL of recombinant mouse IL-12 (Biolegend). Cells were fixed with PBS/2%PFA for 20min, permeabilized in 90% methanol for 30 min on ice and stained for CXCR3, CD4, Foxp3 and PY693-STAT4. For ex-vivo Treg cell stimulation, isolated Treg cells were cultured for 3 days with IL-2 at 200U/mL ± IL-12 at 25 ng/mL (Biolegend) and PMA/ionomycin/BrefeldinA the last 4 hours before staining for IFN-γ and Foxp3. All flow cytometry acquisitions were performed on a Fortessa cytometer using DIVA software (BD Biosystems) and analyzed using FlowJo (Tree Star).

Graft versus host disease

Eight weeks old Balb/c mice were lethally irradiated (8.5–9 Gy) 4 hours prior reconstitution with 5.106 T cell depleted bone marrow cells alone or in presence of 107 spleen cells from C57BL/6 Foxp3EGFPCre, Foxp3EGFPCreRbpjΔ/Δ or Foxp3EGFPCreNotch1Δ/Δ mice. T cell deplete bone marrow was prepared using CD90.2 microbeads (Miltenyi Biotech). Clinical GVHD score was evaluated every 2 to 3 days by assessment of five clinical parameters as followed: Weight loss (<10%, grade 0; >10% to <20%, grade 1; >20%, grade 2), posture (Normal, grade 0; Hunching noted only at rest, grade 1; Severe hunching and/or impairs movement, grade 2), activity (Normal, grade 0; Mild to moderately decreased, grade 1; Stationary unless stimulated, grade 2), fur texture (Normal, grade 0; Mild to moderate ruffling, grade 1; Severe ruffling/poor grooming, grade 2) and skin integrity (Normal, grade 0; Scaling of paws/tail, grade1; Obvious areas of denuded skin, grade 2). In selected experiments, mice were sacrificed 5 days post transplantation and donor H-2KdH-2Kb+ T cells were evaluated for apoptosis, cytokine production and Foxp3 expression.

Adoptive transfer induced Colitis

Naïve (CD4+CD45RBhighGFP−) and Treg (CD4+GFP+) cells are respectively isolated from the spleen of CD45.1 and CD45.2 Foxp3 or Foxp3EGFPCreRosa26N1c/N1c mice. Colitis was induced in RAG1-deficient males by i.p. injection of 5.105 CD45.1 naive ± 2.105 Treg cells. Mice were weighed and monitored for signs of disease twice weekly.

Suppression assays

CD4+ T cells were isolated using a CD4 negative isolation kit (Miltenyi), then labeled with CellTrace™ Violet Cell Proliferation dye (Life technologies) according to the manufacturer’s instructions and used as responder cells. Treg (CD4+GFP+) cells were isolated on FACSAria and used as suppressor cells. Responders were used at a fixed concentration of 105 cells per well and stimulated for 3 days with 2 μg/mL of soluble anti-CD3 antibody and 5 μg/mL of soluble anti-CD28 antibody in the presence of 4.105 feeder Rag1−/− spleen cells in 96-well, round-bottom plates in triplicate.

Gene-expression profiling

Spleen Treg (CD3+CD4+GFP+) cells were double-sorted from 6 week old male Foxp3EGFPCre, Foxp3EGFPcreRbpjΔ/Δ, Foxp3EGFPcreRosa26N1c/N1c and Foxp3EGFPcreRosa26N1c/N1cRbpjΔ/Δ mice (n=3–4 per group). Cells were collected directly into TRIzol. RNA was purified and used for probe synthesis for hybridization to Affymetrix Mouse Gene M1.0 ST microarrays. Raw data were background-corrected and normalized with the RMA algorithm in the GenePattern software package [49].

ChIP assays

Chromatin immunoprecipitation on purified Treg cells was performed with Agarose ChIP Kit (Pierce) and anti-RBPJ (Cell signaling), anti-Notch1 (biolegend), anti- Foxp3 (MBL), anti-Histone H3 trimethylated on Lysine 4 (H3K4me3) (abcam), anti-dimethylated on Lysine 27 (H3K27me2) (Millipore) and respective isotype control antibodies. Purified DNA was subjected to real-time PCR with primers flanking RBPJ binding site at Ifng CNS-22 or with primers flanking Foxp3 binding sites on Pde3b and Ikzf2 as previously described 40 37.

Histology

Pancreatic inflammation was scored based on the degree of inflammatory cellular infiltrations present in the islets of Langerhans: 0, no inflammation; 1, mild inflammatory infiltrates; 2, periinsulitis; 3, moderate and diffuse or severe and focal insulitis; 4, severe and diffuse insulitis; 5, severe insulitis and destruction of the tissue. For colitis experiments, colon sections were stained by H&E and scored as followed: 0, no inflammation; 1, mild, scattered infiltrates; 2, moderate infiltrates without loss of epithelium integrity; 3, moderate and diffuse or severe inflammation; 4, Severe inflammation associated with loss of the epithelial barrier integrity.

Autoantibody arrays

Screening for a broad panel of IgG autoantibodies was performed with autoantibody arrays (University of Texas Southwestern Medical Center, Genomic and Microarray Core Facility) as described [50].

Methylation analysis

The methylation status of Foxp3 Treg-specific demethylation region (TSDR or CNS2) in thymic and splenic Treg cells of 8 weeks old male mice was assessed by bisulfite sequence analysis, as described [51]. The TSDR of converted DNA was amplified by methylation-specific primer sequences: Foxp3 CNS2 Forward 5′-TATTTTTTTGGGTTTTGGGATATTA-3′ (forward) and Foxp3 CNS2 Reverse 5′-AACCAACCAACTTCCTACACTATCTAT-3′. The PCR product was subcloned and sequenced [51]. Blast analyses were done by comparing the resulting sequences with converted Foxp3 gene sequences.

Confocal microscopy

Treg cells were purified and incubated on pre-coated coverslip (poly-L-lysin 50μg/mL, ± anti-CD3 0.1 or 1 μg/mL for low and high dose respectively) at 37°C for 30 min in RPMI/10%FCS. After fixation with PBS/4% paraformaldehyde, cells were permeabilized with PBS/0.1% saponin and blocked on PBS/4% bovine serum albumin (BSA). Cells were incubated with 1:100 diluted rabbit anti-Foxo1 (C29H4, Cell Signaling) followed by 1:500 diluted Alexa fluor 555-anti rabbit secondary antibody (Life technologies) in PBS/1%BSA. Slides were mounted with gold anti-fade reagent with DAPI (Invitrogen). Images were acquired with a Zeiss LSM700 confocal microscopy and ZEN imaging software. Five to 10 fields were selected randomly and total cells in the field were analyzed for percentage of Foxo1 nuclear localization using ImageJ software. Percentage of nuclear Foxo1 localization was obtained by the formula: 100 × corrected nuclear fluorescence/corrected total cell fluorescence and corrected fluorescence was obtained by the formula: Integrated Density – (Area of selected cell or nucleus × Mean fluorescence of background).

In vitro induced Treg cell generation

Naive CD4+CD62LhiCD44lo T cells were isolated from spleen using FACS Aria (purity>98%, data not shown). Cells are stimulated in vitro with coated anti-CD3 (2μg/mL) and anti-CD28 (5μg/mL) for 5 days in the presence of different concentrations of rhTGF-β1 (0, 1, 2 or 5 ng/mL) [52].

Statistical analysis

Data were analyzed by paired and unpaired two-tailed Student’s t-test, one and two way ANOVA with post test analyses and log-rank test, as indicated. Differences in mean values were considered significant at a p < 0.05.
  52 in total

1.  Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.

Authors:  Q-Z Li; J Zhou; A E Wandstrat; F Carr-Johnson; V Branch; D R Karp; C Mohan; E K Wakeland; N J Olsen
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Notch signaling regulates mouse and human Th17 differentiation.

Authors:  Shilpa Keerthivasan; Reem Suleiman; Rebecca Lawlor; Justine Roderick; Tonya Bates; Lisa Minter; Juan Anguita; Ignacio Juncadella; Brian J Nickoloff; I Caroline Le Poole; Lucio Miele; Barbara A Osborne
Journal:  J Immunol       Date:  2011-06-17       Impact factor: 5.422

3.  Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription.

Authors:  Alessandro Barbarulo; Paola Grazioli; Antonio F Campese; Diana Bellavia; Giuseppina Di Mario; Maria Pelullo; Ambra Ciuffetta; Sara Colantoni; Alessandra Vacca; Luigi Frati; Alberto Gulino; Maria Pia Felli; Isabella Screpanti
Journal:  J Immunol       Date:  2011-04-20       Impact factor: 5.422

4.  Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.

Authors:  Naoshi Sugimoto; Takatoku Oida; Keiji Hirota; Kyoko Nakamura; Takashi Nomura; Takashi Uchiyama; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2006-06-13       Impact factor: 4.823

Review 5.  Regulation of FOXO protein stability via ubiquitination and proteasome degradation.

Authors:  Haojie Huang; Donald J Tindall
Journal:  Biochim Biophys Acta       Date:  2011-01-14

6.  Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis.

Authors:  Kisha Piggott; Jiusheng Deng; Kenneth Warrington; Brian Younge; Jessica T Kubo; Manisha Desai; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

7.  Foxo transcription factors control regulatory T cell development and function.

Authors:  Yann M Kerdiles; Erica L Stone; Daniel R Beisner; Daniel L Beisner; Maureen A McGargill; Irene L Ch'en; Christian Stockmann; Carol D Katayama; Stephen M Hedrick
Journal:  Immunity       Date:  2010-12-14       Impact factor: 31.745

Review 8.  Functions of notch signaling in the immune system: consensus and controversies.

Authors:  Julie S Yuan; Philaretos C Kousis; Sara Suliman; Ioana Visan; Cynthia J Guidos
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

9.  Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia.

Authors:  Keunwook Lee; Ki Taek Nam; Sung Hoon Cho; Prathyusha Gudapati; Yoonha Hwang; Do-Sim Park; Ross Potter; Jin Chen; Emmanuel Volanakis; Mark Boothby
Journal:  J Exp Med       Date:  2012-04-02       Impact factor: 14.307

10.  Epigenetic control of the foxp3 locus in regulatory T cells.

Authors:  Stefan Floess; Jennifer Freyer; Christiane Siewert; Udo Baron; Sven Olek; Julia Polansky; Kerstin Schlawe; Hyun-Dong Chang; Tobias Bopp; Edgar Schmitt; Stefan Klein-Hessling; Edgar Serfling; Alf Hamann; Jochen Huehn
Journal:  PLoS Biol       Date:  2007-02       Impact factor: 8.029

View more
  54 in total

1.  T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during Cryptococcus neoformans Infection.

Authors:  Lori M Neal; Yafeng Qiu; Jooho Chung; Enze Xing; Woosung Cho; Antoni N Malachowski; Ashley R Sandy-Sloat; John J Osterholzer; Ivan Maillard; Michal A Olszewski
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

2.  A Jagged 1-Notch 4 molecular switch mediates airway inflammation induced by ultrafine particles.

Authors:  Mingcan Xia; Hani Harb; Arian Saffari; Constantinos Sioutas; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2018-04-05       Impact factor: 10.793

3.  Deregulation of Long Intergenic Non-coding RNAs in CD4+ T Cells of Lamina Propria in Crohn's Disease Through Transcriptome Profiling.

Authors:  Manuel B Braga-Neto; Joseph M Gaballa; Adebowale O Bamidele; Olga F Sarmento; Phyllis Svingen; Michelle Gonzalez; Guilherme Piovezani Ramos; Mary R Sagstetter; Sayed Obaidullah Aseem; Zhifu Sun; William A Faubion
Journal:  J Crohns Colitis       Date:  2020-01-01       Impact factor: 9.071

Review 4.  Regulatory T cells and asthma.

Authors:  Sheng-Tao Zhao; Chang-Zheng Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Sept.       Impact factor: 3.066

5.  T cells take directions from supporting cast in graft-versus-host disease.

Authors:  Derk Amsen
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

6.  Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands.

Authors:  Jooho Chung; Christen L Ebens; Eric Perkey; Vedran Radojcic; Ute Koch; Leonardo Scarpellino; Alexander Tong; Frederick Allen; Sherri Wood; Jiane Feng; Ann Friedman; David Granadier; Ivy T Tran; Qian Chai; Lucas Onder; Minhong Yan; Pavan Reddy; Bruce R Blazar; Alex Y Huang; Todd V Brennan; D Keith Bishop; Burkhard Ludewig; Christian W Siebel; Freddy Radtke; Sanjiv A Luther; Ivan Maillard
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

7.  Notch Ligand Delta-like 4 Promotes Regulatory T Cell Identity in Pulmonary Viral Infection.

Authors:  Hung-An Ting; Matthew A Schaller; Denise E de Almeida Nagata; Andrew J Rasky; Ivan P Maillard; Nicholas W Lukacs
Journal:  J Immunol       Date:  2017-01-11       Impact factor: 5.422

8.  GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T Cells.

Authors:  Eric Perkey; Dave Maurice De Sousa; Léolène Carrington; Jooho Chung; Alexander Dils; David Granadier; Ute Koch; Freddy Radtke; Burkhard Ludewig; Bruce R Blazar; Christian W Siebel; Todd V Brennan; Jeffrey Nolz; Nathalie Labrecque; Ivan Maillard
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

9.  Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis.

Authors:  Hua Rong; Hongjie Shen; Yueli Xu; Hai Yang
Journal:  Immunology       Date:  2016-09-23       Impact factor: 7.397

Review 10.  Empowering Regulatory T Cells in Autoimmunity.

Authors:  Isaac R Kasper; Sokratis A Apostolidis; Amir Sharabi; George C Tsokos
Journal:  Trends Mol Med       Date:  2016-07-25       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.